Search clinical trials for: antibody-drug conjugate (ADC)
Total 1828 results
-
University of Texas Southwestern Medical CenterNational Institute on Aging (NIA)CompletedMild Cognitive ImpairmentUnited States
-
ADC Therapeutics S.A.CompletedDiffuse Large B-cell LymphomaSpain, United States, Italy, Puerto Rico
-
ADC Therapeutics S.A.RecruitingB-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Spain, Italy, United Kingdom, Belgium, Czechia
-
RemeGen Co., Ltd.Completed
-
ADC Therapeutics S.A.RecruitingDiffuse Large B-Cell Lymphoma | High-grade B-cell LymphomaTaiwan, Korea, Republic of, United States, Brazil
-
ADC Therapeutics S.A.TerminatedMelanoma | Renal Cell Carcinoma | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Pancreas Cancer | Colo-rectal Cancer | Triple-negative Breast Cancer | Head and Neck Cancer Squamous Cell CarcinomaUnited States, Belgium, United Kingdom
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
ADC Therapeutics S.A.Active, not recruitingAdvanced Solid TumorsUnited States, Spain, United Kingdom
-
ADC Therapeutics S.A.RecruitingAdvanced Solid TumorsUnited States, United Kingdom, Spain, France
-
Federal Research Institute of Pediatric Hematology...RecruitingNephroblastoma (Wilms Tumour)Russian Federation
-
MacroGenicsTerminatedMelanoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | Metastatic Castrate Resistant Prostate Cancer | Advanced Solid Tumor, AdultSpain, United States, Australia, Poland
-
Shanxi Province Cancer HospitalCancer Institute and Hospital, Chinese Academy of Medical SciencesRecruiting
-
Open Innovation Partners, Inc.Open Innovation PartnersSuspendedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
RenJi HospitalRecruitingUpper Urinary Tract Urothelial Carcinoma | Kidney Preservation | HER-2 ADC | PD-1antibodyChina
-
Ambrx, Inc.WithdrawnHER2 Mutation-Related Tumors | HER2 Amplified Solid TumorsUnited States
-
Heinrich Elinzano, MDUniversity of Texas; Rhode Island Hospital; Progenics Pharmaceuticals, Inc.CompletedGlioblastoma Multiforme | Gliosarcoma | GBMUnited States
-
RemeGen Co., Ltd.Completed
-
Alphamab (Australia) Co Pty Ltd.RecruitingAdvanced Solid Tumors | Metastatic Solid TumorsAustralia
-
ADC Therapeutics S.A.Withdrawn
-
ADC Therapeutics S.A.WithdrawnDiffuse Large B-Cell LymphomaUnited States
-
ADC Therapeutics S.A.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell LymphomaSpain, United States
-
ADC Therapeutics S.A.TerminatedBreast Cancer | Non Small Cell Lung Cancer | Bladder Cancer | GastroEsophageal CancerUnited States, Belgium
-
ADC Therapeutics S.A.TerminatedAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingAdvanced Breast Cancer | Metastatic Breast CancerChina
-
Fudan UniversityRecruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Breast CancerChina
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...CompletedRefractory or Recurrent CD30+ Hematologic MalignanciesChina
-
RemeGen Co., Ltd.Completed
-
Peking University Cancer Hospital & InstituteUnknown
-
Bliss Biopharmaceutical (Hangzhou) Co., LtdRecruiting
-
Bliss Biopharmaceutical (Hangzhou) Co., LtdRecruiting
-
Jiangsu Cancer Institute & HospitalNot yet recruiting
-
Tianjin Medical University Cancer Institute and...Chongqing University Cancer Hospital; Xiangya Hospital of Central South University and other collaboratorsNot yet recruitingNeoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cance
-
RemeGen Co., Ltd.RecruitingMuscle Invasive Bladder CarcinomaChina
-
RemeGen Co., Ltd.Not yet recruitingNon-small Cell Lung CancerChina
-
Memorial Sloan Kettering Cancer CenterPfizerCompleted
-
Shanghai Institute Of Biological ProductsShanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruiting
-
ADC Therapeutics S.A.RecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaJapan, Belgium, France, Italy, Spain, United Kingdom, United States, Israel, Hungary, Brazil, Switzerland, Poland, Canada, Puerto Rico, Czechia, Netherlands, China, Mexico, Argentina, Chile, Turkey
-
ADC Therapeutics S.A.CompletedRefractory Hodgkin Lymphoma | Relapsed Hodgkin LymphomaUnited States, Spain, United Kingdom, Poland, Belgium, Hungary, Germany, France, Italy, Czechia, Canada
-
ADC Therapeutics S.A.TerminatedDiffuse Large B-Cell Lymphoma | Mantle Cell LymphomaUnited States, Spain, United Kingdom, France, Italy, Belgium
-
ADC Therapeutics S.A.TerminatedRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited States, Belgium, Hungary, Israel, Spain, Switzerland, Poland, France, United Kingdom, Italy
-
ADC Therapeutics S.A.CompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-Cell Lymphoma RefractoryUnited States, United Kingdom, Italy, Switzerland
-
ADC Therapeutics S.A.TerminatedAdvanced Solid TumorsUnited States
-
Chinese PLA General HospitalRecruitingAdvanced Gastroesophageal AdenocarcinomaChina
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruiting
-
Jinling Hospital, ChinaRecruitingCarcinoma | Upper Tract Urothelial Carcinoma | UTUCChina
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States